Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate
Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate
Nov 18, 2020, 2:22pm UTC
https://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine